AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Lake Superior Rural Cancer Care Project part I: An intervention trial
Authors: Elliott, TE Elliott, BA Regal, RR Renier, CM Crouse, BJ Gangeness, DE Witrak, MT Jensen, PB
Citation: Te. Elliott et al., Lake Superior Rural Cancer Care Project part I: An intervention trial, CANCER PRAC, 9(1), 2001, pp. 27-36
Lake Superior Rural Cancer Care Project part II: Provider knowledge
Authors: Elliott, TE Elliott, BA Regal, RR Renier, CM Crouse, BJ Gangeness, DE Witrak, MT Jensen, PB
Citation: Te. Elliott et al., Lake Superior Rural Cancer Care Project part II: Provider knowledge, CANCER PRAC, 9(1), 2001, pp. 37-46
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice
Authors: Langer, SW Sehested, M Jensen, PB
Citation: Sw. Langer et al., Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice, ANN ONCOL, 12(3), 2001, pp. 405-410
Collateral sensitivity to gemcitabine (2 ',2 ' -difluorodeoxycytidine) andcytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
Authors: Bergman, AM Munch-Petersen, B Jensen, PB Sehested, M Veerman, G Voorn, DA Smid, K Pinedo, HM Peters, GJ
Citation: Am. Bergman et al., Collateral sensitivity to gemcitabine (2 ',2 ' -difluorodeoxycytidine) andcytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines, BIOCH PHARM, 61(11), 2001, pp. 1401-1408
Treatment of anthracycline extravasation with dexrazoxane
Authors: Langer, SW Sehested, M Jensen, PB
Citation: Sw. Langer et al., Treatment of anthracycline extravasation with dexrazoxane, CLIN CANC R, 6(9), 2000, pp. 3680-3686
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex
Authors: Hofland, K Petersen, BO Falck, J Helin, K Jensen, PB Sehested, M
Citation: K. Hofland et al., Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex, CLIN CANC R, 6(4), 2000, pp. 1488-1497
A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer
Authors: Sorensen, M Jensen, PB Herrstedt, J Hirsch, FR Hansen, HH
Citation: M. Sorensen et al., A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 829-835
Dexrazoxane in anthracycline extravasation
Authors: Langer, SW Sehested, M Jensen, PB Buter, J Giaccone, G
Citation: Sw. Langer et al., Dexrazoxane in anthracycline extravasation, J CL ONCOL, 18(16), 2000, pp. 3064-3064
Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study
Authors: Hansen, TB Gram, J Jensen, PB Kristiansen, JH Ekelund, B Christiansen, JS Pedersen, FB
Citation: Tb. Hansen et al., Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study, CLIN NEPHR, 53(2), 2000, pp. 99-107
Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment
Authors: Jensen, PB Ekelund, B Nielsen, FT Baumbach, L Pedersen, FB Oxhoj, H
Citation: Pb. Jensen et al., Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment, CLIN NEPHR, 53(1), 2000, pp. 25-32
Repeated digital nerve block for pain control after tenolysis
Authors: Kirchhoff, R Jensen, PB Nielsen, NS Boeckstyns, MEH
Citation: R. Kirchhoff et al., Repeated digital nerve block for pain control after tenolysis, SC J PLAST, 34(3), 2000, pp. 257-258
Plasma Escherichia coli beta-galactosidase as a marker of tumor burden andresponse to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells
Authors: Holst-Hansen, C Stephens, RW Johannessen, BE Jensen, PB Brunner, N
Citation: C. Holst-hansen et al., Plasma Escherichia coli beta-galactosidase as a marker of tumor burden andresponse to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells, LAB INV, 80(5), 2000, pp. 719-724
Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen
Authors: O'Doherty, RM Jensen, PB Anderson, P Jones, JG Berman, HK Kearney, D Newgard, CB
Citation: Rm. O'Doherty et al., Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen, J CLIN INV, 105(4), 2000, pp. 479-488
Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, G(L), G(M)/R-G1) expressed in hepatocytes
Authors: Gasa, R Jensen, PB Berman, HK Brady, MJ DePaoli-Roach, AA Newgard, CB
Citation: R. Gasa et al., Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, G(L), G(M)/R-G1) expressed in hepatocytes, J BIOL CHEM, 275(34), 2000, pp. 26396-26403
A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines
Authors: Jensen, LH Nitiss, KC Rose, A Dong, JW Zhou, JF Hu, T Osheroff, N Jensen, PB Sehested, M Nitiss, JL
Citation: Lh. Jensen et al., A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines, J BIOL CHEM, 275(3), 2000, pp. 2137-2146
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
Authors: Jensen, LH Wessel, I Moller, M Nitiss, JL Sehested, I Jensen, PB
Citation: Lh. Jensen et al., N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance, FEBS LETTER, 480(2-3), 2000, pp. 201-207
Small cell and its stroma: determinant of pan-resistance?
Authors: Sehested, M Jensen, PB
Citation: M. Sehested et Pb. Jensen, Small cell and its stroma: determinant of pan-resistance?, DRUG RESIST, 2(5), 1999, pp. 281-283
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity
Authors: Langer, SW Schmidt, G Sorensen, M Sehested, M Jensen, PB
Citation: Sw. Langer et al., Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity, CLIN CANC R, 5(10), 1999, pp. 2899-2907
Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines
Authors: Theilade, MD Gram, GJ Jensen, PB Cianfriglia, M Rorth, M Hansen, JES
Citation: Md. Theilade et al., Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines, APMIS, 107(9), 1999, pp. 851-858
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
Authors: Jensen, PB Sehested, M Langer, SW Hansen, HH
Citation: Pb. Jensen et al., Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory, CANC TR REV, 25(6), 1999, pp. 377-386
Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone
Authors: Jensen, PB Hansen, TB Frystyk, J Ladefoged, SD Pedersen, FB Christiansen, JS
Citation: Pb. Jensen et al., Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone, CLIN NEPHR, 52(2), 1999, pp. 103-109
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens
Authors: Meersma, GJ Bakker, M Groen, HJM Van der Zee, AGJ Jensen, PB Giaccone, G De Vries, EGE Smit, EF
Citation: Gj. Meersma et al., A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens, ANTICANC R, 19(2A), 1999, pp. 1309-1315
Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation of cleavable-complex formation by etoposide but not by amsacrine
Authors: Sorensen, M Sehested, M Jensen, PB
Citation: M. Sorensen et al., Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation of cleavable-complex formation by etoposide but not by amsacrine, MOLEC PHARM, 55(3), 1999, pp. 424-431
Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase II alpha gene
Authors: Falck, J Jensen, PB Sehested, M
Citation: J. Falck et al., Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase II alpha gene, J BIOL CHEM, 274(26), 1999, pp. 18753-18758
The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans
Authors: Jensen, PB Kristensen, P Clausen, JT Judge, ME Hastrup, S Thim, L Wulff, BS Foged, C Jensen, J Holst, JJ Madsen, OD
Citation: Pb. Jensen et al., The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans, FEBS LETTER, 447(2-3), 1999, pp. 139-143
Risultati: 1-25 | 26-27